
About Golden Drugs Private Limited
Data last updated:
Golden Drugs Private Limited was a private limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Bal Pharma Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 August 2012.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2012PTC157474. Its GSTIN is 29AAECG9048B1ZK (Karnataka). The company held 2 GST registrations, all of them active.
The company had an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹3.59 Cr. It was formerly known as Golden Drug Private Limited. It was led by directors Ravindrakumar Kothari and Shailesh Dheerajmal Siroya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 10/1 Laxmi Narayan Complex 5th Floor Palace Road, Bangalore, Karnataka, India – 560052.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.8 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹2.55 Cr (net margin -43.9%) and EBITDA of -₹11.88 Lakh (EBITDA margin -2%). Revenue has grown at a compounded annual rate (CAGR) of 87% over three years.
The company had about 80 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had open charges of ₹20 Cr and satisfied charges of ₹24.5 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it. The company has 3 deals on record (2 funding rounds, 1 acquisition), with disclosed funding of ₹3.58 Cr; the latest was in March 2018. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 1 smaller; the largest is Deep Finechem Private Limited with revenue of ₹6.17 Cr.
The last known website on record is balpharma.com.
Company details
CIN history
Golden Drugs has one previous CIN (Corporate Identification Number): U24232RJ2012PTC039907. The current CIN is U24232KA2012PTC157474, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232KA2012PTC157474 | Current |
| U24232RJ2012PTC039907 | Previous |
Contact details
Golden Drugs Private Limited's registered office is in Bangalore, Karnataka. Its website is balpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address10/1 Laxmi Narayan Complex 5th Floor Palace Road, Bangalore, Karnataka, India – 560052
- IndustryPharma, API Manufacturers
To see the full contact details of Golden Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Golden Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Golden Drugs Private Limited, buy the company report.
Financials of Golden Drugs Private Limited
FY 2024 filings availableGolden Drugs Private Limited reported revenue of ₹5.8 Cr (down 22% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 87%. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.8 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.55 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -43.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Golden Drugs Private Limited, buy the company report.
Board of directors of Golden Drugs Private Limited
Golden Drugs has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravindrakumar Kothari Also directs: Balance Clinics LLP, Bal Pharma Limited, Lifezen Healthcare Private Limited and 2 more | Director | 15 Nov 2018 | 8 Years 0 Months | As last reported |
| Shailesh Dheerajmal Siroya Also directs: Balance Clinics LLP, Bal Pharma Limited, Lifezen Healthcare Private Limited and 3 more | Director | 12 Apr 2018 | 8 Years 7 Months | As last reported |
Peer comparison
Golden Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deep Finechem Private Limited | ₹6.17 Cr (FY 2024) | -38.0% | Dhule, Maharashtra, India | |||
| SM Labs Private Limited | ₹6.16 Cr (FY 2024) | -23.0% | Hyderabad, Telangana, India | |||
| B. Sharda Pharma-Chem Limited | ₹5.93 Cr (FY 2024) | -10.0% | Gujarat, India | |||
| Rati Pushp Intermediates Private Limited | ₹5.92 Cr (FY 2025) | -20.0% | Muzaffar Nagar, Uttar Pradesh, India | |||
| Golden Drugs Private Limitedthis company | ₹5.8 Cr (FY 2024) | -₹2.55 Cr | -43.9% | -22.0% | Bangalore, Karnataka, India | |
| R A C S Pharmachem (India) Private Limited | ₹5.77 Cr (FY 2025) | -51.0% | Chikkaballapur Distri, Karnataka, India |
To see the full peer comparison of Golden Drugs Private Limited, buy the company report.
Auditor
Golden Drugs Private Limited is audited by K N & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K N & Associates | FY 2024 | 013495C |
Shareholding
The shareholding of Golden Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Golden Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Sep 2018 | 100207862 | Tata Capital Financial Services Limited | ₹15 Cr | Satisfied | |
| 15 Oct 2014 | 10528894 | Punjab National Bank | ₹4 Cr | Satisfied | |
| 15 Oct 2014 | 10528892 | Punjab National Bank | ₹5.5 Cr | Satisfied |
To see the full charge records of Golden Drugs Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Golden Drugs Private Limited has 3 deals on record (2 funding rounds, 1 acquisition), with disclosed funding of ₹3.58 Cr; the latest was in March 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Acquisition | ₹7.42 Cr | Buyer: Bal Pharma Limited Seller: Chander Khamesara HUF, 3 individuals |
| Mar 2016 | Funding round | ₹1.47 Cr | Investors: Mayura Jewels (India) Private Limited , 3 individuals |
| Mar 2014 | Funding round | ₹2.12 Cr | Investors: Chander Khamesara HUF, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Golden Drugs Private Limited has 4 court cases on record: 2 filed by Golden Drugs, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Appeal | Filed against the company by M/S.Krishna Kishore Engineering Pvt.Ltd | Disposed |
| High Court | Appeal | Filed against the company by M/S.Krishna Kishore Engineering Pvt.Ltd | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Union of India, Represented by Its Secretary, and 3 others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against A.P.S.Finance Corpn. | Disposed |
To see the full case history of Golden Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Golden Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Golden Drugs has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECG9048B1ZK | Karnataka | Active | 07 Sep 2019 |
| 08AAECG9048B1ZO | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Golden Drugs Private Limited, buy the company report.
Recent activity
Golden Drugs Private Limited has 9 board changes on record since 2016: 2 appointments and 7 cessations. The latest: Ravindrakumar Kothari ceased to be Additional Director on 30 Sep 2019.
7 earlier events are in the company report.
Frequently asked questions
Golden Drugs has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Golden Drugs was a private limited company based in Bangalore, Karnataka, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 27 August 2012 and is registered under CIN U24232KA2012PTC157474. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Golden Drugs was incorporated on 27 August 2012. It is registered with the Registrar of Companies, Bangalore.
Golden Drugs had 2 directors:
- Ravindrakumar Kothari - Director
- Shailesh Dheerajmal Siroya - Director
The CIN (Corporate Identification Number) of Golden Drugs is U24232KA2012PTC157474. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Golden Drugs is at 101 Laxmi Narayan Complex 5th Floor Palace Road, Bangalore, Karnataka, India – 560052.
Golden Drugs can be reached through the website balpharma.com. Its registered office is in Bangalore, Karnataka, India.
The latest financial statements of Golden Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Golden Drugs is 29AAECG9048B1ZK, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAECG9048B1ZO (Rajasthan).
Golden Drugs operated in the pharma industry, in the api manufacturers segment.
Golden Drugs has 3 deals on record (2 funding rounds, 1 acquisition), with disclosed funding of ₹3.58 Cr; the latest was in March 2018.

